e-learning
resources
Amsterdam 2011
Sunday, 25.09.2011
Monitoring with lung function tests in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung function differences between subjects with tobacco smoke-induced COPD (TS-COPD) and biomass smoke-induced COPD (BS-COPD) in an Indian population
B. Brashier, N. Vanjare, V. Vincent, J. Londhe, S. Madas, S. Juvekar, P. Barnes, S. Salvi (Pune, India; London, United Kingdom)
Source:
Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Session:
Monitoring with lung function tests in airway diseases
Session type:
Thematic Poster Session
Number:
918
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Brashier, N. Vanjare, V. Vincent, J. Londhe, S. Madas, S. Juvekar, P. Barnes, S. Salvi (Pune, India; London, United Kingdom). Lung function differences between subjects with tobacco smoke-induced COPD (TS-COPD) and biomass smoke-induced COPD (BS-COPD) in an Indian population. Eur Respir J 2011; 38: Suppl. 55, 918
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Comparison of airway cellular and mediator profiles between tobacco smoke-induced COPD and biomass fuel exposure-induced COPD in an Indian population
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Oral and nasal microbiota in healthy, tobacco smoke COPD (TSCOPD) and biomass smoke COPD (BMSCOPD) subjects from India
Source: International Congress 2016 – How the understanding og molecular and genomic crosstalk is helping to diagnose lung disease
Year: 2016
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
COPD in Chinese nonsmokers
Source: Eur Respir J 2009; 33: 509-518
Year: 2009
COPD phenotypes in biomass smoke- versus tobacco smoke-exposed Mexican women
Source: Eur Respir J 2014; 43: 725-734
Year: 2014
Comparison of serum cytokine profiles among biomass- and tobacco smoke induced chronic obstructive pulmonary disease (COPD) patients in a South Indian population: A pilot study
Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Year: 2017
Genetic differences in COPD secondary to wood smoke and tobacco smoking
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites
Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Year: 2015
Differences in COPD: Smokers versus non smokers
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Airway epithelial cell apoptosis and inflammation in COPD, smokers and nonsmokers
Source: Eur Respir J 2013; 41: 1058-1067
Year: 2013
Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
Source: Eur Respir J 2007; 30: 467-471
Year: 2007
Environmental tobacco smoke and health in the elderly
Source: Eur Respir J 2002; 19: 172-181
Year: 2002
Comparative study of respiratory symptoms, lung function, BMI and exercise capacity in patients with COPD associated with tobacco smoke (TS) and biomass smoke (BS) exposure
Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care
Year: 2012
Asthma control is worse in asthmatic smokers compared to non-smokers with similar lung function
Source: Annual Congress 2006 - New investigational approaches to smoking and smoking cessation
Year: 2006
Corticosteroids improve lung function and quality of life in subjects with biomass fuel (BMF) smoke exposures induced COPD
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015
Endothelial function in patients with tobacco and biomass smoke-related COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers)
Source: International Congress 2017 – Smoking and health hazards
Year: 2017
Tobacco use in relation to COPD and asthma
Source: Eur Respir J 2007; 29: 438-445
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept